SCHEMBL20100813

SCHEMBL20100813

CCCCCCCCCN(CCCC)CCC1CCN(C(=O)CN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)CC1

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ GNAI3 P08754 8/20 0.50
▸ GNAO1 P09471 8/20 0.50
▸ GNAI1 P63096 8/20 0.50
▸ BCHE P06276 4/20 0.39
▸ ACHE P22303 2/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ EPHX2 P34913 1/20 0.37
▸ ITGB3 P05106 2/20 0.36
▸ ITGA2B P08514 2/20 0.36
▸ PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23426287 0.99 GNAI3 (0.51) GNAI3GNAO1GNAI1BCHEACHE
SCHEMBL19040739 0.99 GNAI3 (0.51) GNAI3GNAO1GNAI1BCHEACHE
SCHEMBL19032620 0.99 GNAI3 (0.51) GNAI3GNAO1GNAI1BCHEACHE
SCHEMBL19040735 0.99 GNAI3 (0.51) GNAI3GNAO1GNAI1BCHEACHE
SCHEMBL19040754 0.97 GNAI3 (0.52) GNAI3GNAO1GNAI1BCHEACHE
SCHEMBL22920299 0.94 GNAI3 (0.49) GNAI3GNAO1GNAI1BCHEACHE
SCHEMBL19032551 0.93 GNAI3 (0.46) GNAI3GNAO1GNAI1BCHEACHE
SCHEMBL25364803 0.92 GNAI3 (0.51) GNAI3GNAO1GNAI1BCHEACHE
SCHEMBL21421515 0.91 GNAI3 (0.43) GNAI3GNAO1GNAI1BCHEACHE
SCHEMBL19040674 0.91 GNAI3 (0.43) GNAI3GNAO1GNAI1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458590-B9 POLYNUCLEOTIDES ENCODING -GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE MODERNATX INC (US) 2021-08-18 — — EP disclosed
EP-3458590-B1 POLYNUCLEOTIDES ENCODING -GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE MODERNATX INC (US) 2021-01-27 — — EP disclosed
WO-2018081459-A1 MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF MODERNATX, INC. (US) 2018-05-03 — — WO disclosed
Send feedback